TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CPH Group AG Class A ( (CH:CPHN) ) has provided an announcement.
CPH Group AG has adjusted its earnings forecast for 2025, anticipating an EBITDA of CHF 50 million, lower EBIT, and a reduced net result due to challenges in the global pharmaceutical packaging market, unfavorable exchange rates, and increased costs. Despite these challenges, the company expects revenue to remain above the previous year and continues to focus on cost reductions and process optimizations to improve profitability. The company remains optimistic about its medium-term growth prospects, driven by trends in health, demographics, and energy, and expects stable business development and positive earnings in 2026.
The most recent analyst rating on (CH:CPHN) stock is a Hold with a CHF73.00 price target. To see the full list of analyst forecasts on CPH Group AG Class A stock, see the CH:CPHN Stock Forecast page.
More about CPH Group AG Class A
CPH Group AG operates in the pharmaceutical packaging industry, focusing on products and services related to health and demographics, as well as energy. The company is committed to achieving medium-term growth targets, with an emphasis on sales growth, EBITDA margins, and free cash flow margins.
Average Trading Volume: 688
Technical Sentiment Signal: Buy
Current Market Cap: CHF421.2M
For a thorough assessment of CPHN stock, go to TipRanks’ Stock Analysis page.